Driving Successful Brexit Transition Planning

A Kinapse Best Practice Guide

Are you Brexit Ready?

January 2021 marked the end of the UK’s transition period from the EU and with it the departure from the EU’s regulatory system. Which means that any medicinal products that were licensed via the Centrally Authorised Procedure will automatically have been transferred by the MHRA to a GB Licence unless the MA Holder decided to opt out.

The MHRA has released guidelines highlighting how licences for the UK will operate moving forward but that doesn’t necessarily mean the transition will be straight forward.  


Did you know that you need to make updates to your licenced products between now and January 2022 to ensure you are compliant with new UK rules? There is plenty to do to avoid being out of compliance and risk having an audit finding or an out of stock situation the guide below provides you with a quick overview of all the things you need to know to get prepared for marketing your products in a post Brexit UK.  


Please complete this form to download our free flyer, as we provide you with a quick overview of all the things you need to know to get prepared for marketing your products in a post Brexit UK.

Download your copy

Unless you have previously signed up to marketing emails, we will delete your data after delivering your copy of the white paper. For full details, read our Privacy Policy.

Full Width Content